BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » Monthly Archive for: 'October 17th, 2016'
Per-Olof Berggren has been elected to The National Academy of Medicine

Per-Olof Berggren has been elected to The National Academy of Medicine

Posted in: Company news|October 17, 2016

Per-Olof Berggren has been elected to The National Academy of Medicine The National Academy of Medicine announced today the election of 70 U.S. members and 9 international members during its annual meeting. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have …

Read more »

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications May 13, 2026
  • Framsteg för stamcellsterapi vid typ 1-diabetes
    Framsteg för stamcellsterapi vid typ 1-diabetes May 13, 2026
  • Western diet can cause permanent pancreatic damage, new study finds
    Western diet can cause permanent pancreatic damage, new study finds June 13, 2025
  • Årsstämma 26 juni 2025
    Årsstämma 26 juni 2025 June 10, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved